Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marco Weimer"'
Autor:
Hans H. Lindén, Marco Weimer, Jarkko Ketolainen, Staffan Folestad, Wim Oostra, Per Öhrngren, Marcel de Matas, Jukka Rantanen, Thomas De Beer, João A. Lopes
Publikováno v:
European Journal of Pharmaceutical Sciences. 90:2-7
The regulatory and technical landscape of the pharmaceutical field is rapidly evolving from one focused predominantly on development of small molecules, using well established manufacturing technologies towards an environment in which biologicals and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::372fb4eadf9959405267853f4e3228c9
https://doi.org/10.1016/j.ejps.2016.04.024
https://doi.org/10.1016/j.ejps.2016.04.024
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 97:78-89
Scope of the study was (1) to develop a lean quantitative calibration for real-time near-infrared (NIR) blend monitoring, which meets the requirements in early development of pharmaceutical products and (2) to compare the prediction performance of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2582df95e5f22658bf3f9873da908e2
https://doi.org/10.1016/j.ejpb.2015.10.002
https://doi.org/10.1016/j.ejpb.2015.10.002
Autor:
Staffan Folestad, Marcel de Matas, Jukka Rantanen, Thomas De Beer, Hans H. Lindén, Wim Oostra, João A. Lopes, Marco Weimer, Buket Aksu, Jarkko Ketolainen
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 47(2)
Substantial changes in Pharmaceutical R&D strategy are required to address existing issues of low productivity, imminent patent expirations and pressures on pricing. Moves towards personalized healthcare and increasing diversity in the nature of port
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12463273a4543287abf1dd990e1180dc
https://pubmed.ncbi.nlm.nih.gov/22749874
https://pubmed.ncbi.nlm.nih.gov/22749874